What Is nano<mHAP>? A Complete Breakdown of SANGI's Medical-Grade Nano Hydroxyapatite

TAKEAWAYS

•What it is: nano<mHAP> (Medical Hydroxyapatite) is a proprietary oral care active ingredient developed by Japan's SANGI Co., Ltd. Its INCI name is Hydroxyapatite, CAS No. 1306-06-5, and chemical formula Ca₁₀(PO₄)₆(OH)₂.

•Particle specifications: Primary particle size averages approximately 50nm (two-digit nanoscale), with a rod-shaped morphology, zero needle-shaped particles, and no surface modification — pure, unmodified biomimetic hydroxyapatite.

•Official certification: Approved in 1993 by Japan's Ministry of Health and Welfare as an anti-caries active ingredient, with three officially recognized functions: bacterial adsorption and plaque removal, micro-filling of surface defects, and remineralization of sub-surface enamel lesions.

•Toothpaste tablet compatibility: Supplied in solid powder form, nano<mHAP> is naturally suited to toothpaste tablet formulations — no emulsification required, with excellent compatibility with common tablet bases such as microcrystalline cellulose and sorbitol.

•Safety profile: Exceptionally biocompatible — non-toxic, non-irritating, and safe to swallow. The EU SCCS latest assessment confirms it is safe in toothpaste at concentrations up to 29.5%, making it an ideal active ingredient for children's toothpaste tablet formulations.

If you have been closely tracking the latest developments in premium B2B oral care formulations, there is one ingredient name you simply cannot ignore: nano<mHAP>.

In the rapidly growing toothpaste tablet segment, the core challenge for brands has never been "whether to launch" — it has always been "how to convince consumers that a solid tablet actually works." The formulation logic of traditional toothpaste does not translate directly to tablets, yet consumer expectations for efficacy remain just as high.

This is exactly where nano<mHAP> enters the picture.

As formulators, brand owners, and product developers, we cannot rely solely on supplier brochures. We need cold, compliance-backed data and a scientific track record that stands the test of time. Today, we are going to do a thorough, no-fluff breakdown of SANGI's nano<mHAP> — from its NASA origins and government-certified mechanisms to its precise application logic in toothpaste tablet formulations.

Setting the Stage: Who Is SANGI?

Before we dive into the data, let us understand the company behind this ingredient.

SANGI Co., Ltd. was founded in Tokyo in 1974 by Shuji Sakuma, initially as a patent trading company. In 1976, SANGI acquired a patent from the U.S. National Aeronautics and Space Administration (NASA) relating to tooth remineralization — and that is where this story truly begins. NASA had been researching ways to protect astronauts' teeth and bones from mineral loss in a zero-gravity environment, proposing the use of a hydroxyapatite precursor to restore these essential minerals.

SANGI saw a far greater opportunity: hydroxyapatite is the very mineral that makes up 97% of tooth enamel and 70% of dentin. If it could be synthesized and incorporated into an oral care product, could it directly repair mineral loss during daily brushing?

In 1980, in collaboration with dental universities and a manufacturing partner, SANGI launched APADENT — the world's first hydroxyapatite remineralizing toothpaste. At a time when ordinary toothpastes sold for around 200 yen per tube, APADENT was priced at 2,800 yen and marketed as "the most expensive toothpaste in the world." This was not a gimmick — it was the birth of an entirely new product category.

SANGI went on to launch the globally recognized APAGARD brand in 1985. To date, SANGI's hydroxyapatite oral care products have achieved cumulative global sales of over 150 million units, reaching consumers across 19 countries and regions.

The Chemical Identity: What Exactly Is nano<mHAP>?

When introducing a premium ingredient into a toothpaste tablet formulation, you need a precise understanding of its chemical identity for regulatory filings and compliance documentation.

The core active component of nano<mHAP> is Hydroxyapatite. Here are its key regulatory parameters:

It is worth highlighting that nano<mHAP> is supplied in solid powder form — unlike most liquid-suspension nHAp ingredients on the market. This makes it a natural fit for toothpaste tablet manufacturing: no emulsification or dehydration steps are required, significantly simplifying the formulation development process.

Official Certification: What Does "Medical-Grade" (mHAP) Actually Mean?

There are many hydroxyapatite ingredients on the market, but SANGI's is designated <mHAP> — Medical Hydroxyapatite. This "medical-grade" designation is not a marketing claim; it is a proprietary name backed by rigorous government certification.

To obtain official recognition for its anti-caries efficacy, SANGI conducted 15 years of foundational laboratory research, followed by large-scale field trials on Japanese schoolchildren carried out by two universities on their behalf. In 1993, Japan's former Ministry of Health and Welfare formally approved SANGI's proprietary hydroxyapatite as "Medical Hydroxyapatite (<mHAP>)," officially recognizing the following three anti-caries mechanisms:

① Bacterial Adsorption and Plaque Removal

The surface of nano<mHAP> particles binds to Streptococcus mutans and other decay-causing oral bacteria. During the process of chewing a toothpaste tablet and brushing, these bacteria are physically carried away from the tooth surface, reducing plaque accumulation at its source. For toothpaste tablet brands, this is a highly compelling efficacy claim — one of the most common consumer concerns about solid oral care products is "can a tablet really clean properly?" This government-certified mechanism provides the most authoritative answer possible.

② Micro-filling of Surface Defects

Tooth surfaces are far from smooth at the microscopic level. Daily wear, acid erosion, and abrasion create countless invisible micro-scratches and fissures on enamel — and these are precisely where plaque bacteria take hold. nano<mHAP> fills these microscopic defects directly, restoring surface smoothness, reducing the area available for plaque adhesion, and delivering a visible improvement in natural tooth brightness. This function is fully preserved in the toothpaste tablet format: nano<mHAP> activates its repair mechanism upon contact with saliva during use.

③ Remineralization of Sub-Surface Enamel Lesions

This is nano<mHAP>'s most fundamental function. Every day, teeth undergo a dynamic cycle of demineralization and remineralization: acids from food and plaque bacteria dissolve minerals from beneath the enamel surface (demineralization), while calcium and phosphate ions in saliva attempt to restore them (remineralization). nano<mHAP> penetrates directly into early sub-surface demineralized zones — incipient caries lesions — replenishing calcium and phosphate ions from within, and halting the progression of early-stage tooth decay. For toothpaste tablet brands positioning around "fluoride-free remineralization," this is the most powerful scientific foundation available.

Nano-Morphology: Why Does 50nm Matter?

In the material science of nano-hydroxyapatite, particle size and morphology directly determine how effectively the ingredient interacts with tooth structure. This is not a detail that can be overlooked.

SANGI's original <mHAP> operated at the three-digit nanoscale (primary particle size averaging approximately 100nm). In 2003, SANGI achieved a pivotal technical breakthrough, successfully reducing the particle size to the two-digit nanoscale (averaging approximately 50nm), and formally designating the ingredient nano<mHAP>.

This reduction in particle size delivers three significant performance improvements — particularly relevant in the toothpaste tablet format:

•Deeper penetration: The 50nm particle size allows the ingredient to more effectively enter the microstructure of enamel after the tablet dissolves, reaching deeper demineralized zones and compensating for the shorter contact time inherent to solid-format products compared to conventional toothpaste.

•Higher remineralization efficiency: The dramatic increase in surface area at 50nm significantly raises the rate and total volume of calcium and phosphate ion release within the limited brushing window.

•Superior anti-sensitivity performance: nano<mHAP> effectively occludes exposed dentinal tubules, forming a stable protective coating that blocks external stimuli (cold, heat, acid, sweetness) from reaching the dental nerve — making nano<mHAP>-containing toothpaste tablets a natural fit for "sensitivity relief" product lines.

Furthermore, nano<mHAP> particles are confirmed to be rod-shaped with zero needle-shaped particles present. This is a critical point for regulatory compliance — needle-like nanoparticles are subject to intense scrutiny in nanotoxicology, and rod-shaped morphology is one of the core safety criteria evaluated by the EU SCCS.

Safety Data: What Formulators and Brand Owners Need to Know

Today's consumers are acutely focused on the safety of "nano" ingredients. If you are building a toothpaste tablet brand, you will inevitably face questions about nanomaterial safety. The good news is that nano<mHAP> has an exceptionally well-documented safety profile.

Biocompatibility

As a biomimetic material, nano<mHAP> is structurally identical to the mineral composition of human bones and teeth. It is non-toxic, non-irritating, and completely safe to swallow — in the stomach, it breaks down into calcium and phosphate, which are absorbed as nutrients. This characteristic is especially important for toothpaste tablets: since a small amount is inevitably ingested during chewing, nano<mHAP>'s swallowable safety profile makes it the ideal active ingredient for children's toothpaste tablet formulations.

EU SCCS Safety Assessment

In the European market, the EU Scientific Committee on Consumer Safety (SCCS) has conducted multiple rounds of rigorous evaluation on nano-hydroxyapatite. The latest assessment concludes that nano-hydroxyapatite meeting specific morphological requirements (rod-shaped, non-needle) is safe at the following concentrations:

This conclusion removes the key regulatory barrier for brands using high-quality nano-hydroxyapatite globally, and provides robust regulatory backing for toothpaste tablet products entering European and North American markets.

A Compliant Fluoride-Free Pathway

As more consumers worldwide seek fluoride-free oral care solutions, the toothpaste tablet category is naturally aligned with this trend — many consumers who choose tablets are actively looking for cleaner, more natural alternatives. nano<mHAP> delivers remineralization efficacy comparable to fluoride, while additionally providing bacterial adsorption and physical micro-filling functions. This is a genuine, science-backed upgrade — not a simple substitution.

Storage and Handling: Key Operational Details for Manufacturers

If you are planning to incorporate nano<mHAP> into your toothpaste tablet production formulation, your procurement and production teams need to be aware of the following operational guidelines:

Storage Conditions

nano<mHAP> is supplied in solid powder form. Compared to liquid-suspension nHAp ingredients, it offers significantly higher storage stability and simpler handling:

•Store at ambient temperature (15–25°C) in a dry, light-protected environment

•Keep containers tightly sealed to prevent moisture absorption and clumping, which can affect dispersibility

•No cold chain required — standard ambient-temperature logistics are sufficient, reducing supply chain costs

Toothpaste Tablet Formulation Operations

•Add during the dry-blending stage; mix thoroughly with other powder excipients (microcrystalline cellulose, sodium bicarbonate, mint powder, etc.) to ensure uniform particle distribution

•Verify moisture content of the blend prior to tableting to prevent hardness inconsistencies caused by moisture uptake

•Demonstrates excellent physical compatibility with common toothpaste tablet bases (microcrystalline cellulose, sorbitol, erythritol) without interfering with tablet formation or structural integrity

Final Thoughts

When you look closely at the data behind nano<mHAP>, it becomes clear why SANGI has maintained its position as a global technology leader in oral care for decades. They did not simply create an ingredient — they built an irreplicable scientific foundation through 15 years of clinical data, government-level certification, and continuous nanoscale innovation.

Rod-shaped morphology, zero needle-shaped particles, three government-certified anti-caries mechanisms, and EU SCCS safety backing — these are not marketing claims. They are exactly what formulators and brand owners need to see when selecting a core active ingredient.

For B2B brands building premium toothpaste tablet product lines, nano<mHAP> offers far more than an active ingredient. It delivers a complete brand narrative system: from NASA space technology to Japanese government certification, from the 50nm nano breakthrough to 150 million units of market validation — every data point is powerful ammunition for the story you tell your end consumers.

In a category where consumers are actively redefining what "oral care" should look like, choosing a core ingredient with genuine scientific depth is where the gap between you and your competitors begins.

Ready to Formulate with nano<mHAP>?

We specialize in OEM/ODM toothpaste tablet manufacturing and work with premium active ingredients including nano<mHAP> to help brands build differentiated, science-backed product lines.

Whether you are developing a fluoride-free remineralizing tablet, a sensitivity-relief formula, or a children's oral care range, our team is ready to support your formulation from concept to finished product.

Get in touch with us today to discuss your toothpaste tablet project.

[Contact Us / Request a Sample / Get a Quote]

References

[1] NASA Spinoff. (2024). Semiconductor Research Leads to Revolution in Dental Care.

[2] SANGI CO.,LTD. MEDICAL HYDROXYAPATITE — Our Pioneering Role.

[3] SANGI Europe. HYDROXYAPATITE — SANGI's original ingredient nano<mHAP>.

[4] European Commission SCCS. (2023 ). Scientific Opinion on Hydroxyapatite (nano) (SCCS/1643/22).

[5] SANGI CO.,LTD. MILESTONES — Our History.